Related Links:
For additional information about the WALK Trial, please refer to the following links.
The WALK Trial has fully completed enrollment. No further patients can be included. A further trial for the therapy may be initiated in 2012.
The ROX Medical WALK Trial is a clinical research study in the United States for men and women that have been diagnosed with severe and very severe Chronic Obstructive Pulmonary Disease (COPD).
The purpose of the WALK Trial is to study the safety and effectiveness of the Coupler and to assess whether patients with acute COPD can achieve a greater exercise capacity, a reduction in hypoxemia, an overall reduction in COPD symptoms, and improved condition with the device.
You can check back to this website and www.clinicaltrials.gov for the most up-to-date information about our ongoing clinical studies.
The purpose of the WALK Trial is to study the safety and effectiveness of the Coupler and to assess whether patients with acute COPD can achieve a greater exercise capacity, a reduction in hypoxemia, an overall reduction in COPD symptoms, and improved condition with the device.
You can check back to this website and www.clinicaltrials.gov for the most up-to-date information about our ongoing clinical studies.
Caution: Investigational device. Limited by United States law to investigational use.
Learn more about the ROX Solution.